Clinical trial
The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial
NCT02683707 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- May 25, 2017
- Enrollment
- 212 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.